Download Free Sample
Author
Sravani is a proficient Business Analyst with an MBA and a background in Computer Science, with seven years of expe.....
D-Mannose Market: By Product Type, By Application, and Region Forecast 2019-2030
D-Mannose Market: By Product Type, By Application, and Region Forecast 2019-2030
D-Mannose Market size was valued at US$ 726.9 million in 2023 and is expected to witness a CAGR of 3.8%from 2024-2030. D- Mannose is a type of simple sugar related to glucose and is found in many fruits like oranges, apples, peaches, and so on. D-mannose is also present naturally in some of our body cells. Some other names of D- mannose are semi-nose, and mannose. D- Mannose is used therapeutically for the treatment of carbohydrate-deficient glycoprotein syndrome type 1-b as well as urinary tract infections and kidney infections. The glycosylation of several proteins in the human body requires the sugar D-mannose, which belongs to the aldohexose group of carbohydrates. D-Mannose dissolves readily in water and just marginally in ethanol. It mostly exists in the form of a ring, which can be either a pyranose or a furanose. According to NIH, UTIs occur at least 4 times more frequently in females than males, Forty percent of women in the United States will develop a UTI during their lifetime. Thus, the prevalence of UTI will boost the market to its highest.
Also, the new trend of health and environmental consciousness, which makes the health benefits of D-mannose such as Anti-inflammatory properties and potential to reduce genetic conditions also the possibility and practice of substituting sugar with D-mannose as an alternative will drive the market. Even though its health benefits are visible to the world, the side effects such as Gastric issues, kidney overload, and sometimes allergy reactions hinder the usage of it thus acting as a restraint. ?Emerging economies, which is driving the demand for health supplements, including D-mannose,?as disposable income rises and consumer awareness of health products increases, more individuals in these markets are looking for natural solutions to health issues, especially urinary tract infections (UTIs) and related conditions.
Study Period
2024-2030Base Year
2023CAGR
3.6%Largest Market
North AmericaFastest Growing Market
Europe
According to a research study, About 10% of women will get a UTI yearly in which Escherichia coli causes the vast majority of UTIs, followed by Klebsiella. Apart from the other medications prescribed by doctors, D-Mannose has been used as a prophylactic agent and is one of the main supplements prescribed which prevent UTI. Additionally, USA healthcare spending grew by 4.1% to reach $4.5 trillion in 2022, faster than the increase of 3.2% in 2021. The growth in 2022 reflected strong growth in Medicaid and private health insurance spending which indicates a strong trend in the increase in spending on healthcare which in turn drives the market up. Moreover, according to TPW media, the increasing demand for healthier food choices reflects a paradigm shift in consumer preferences, driven by a desire for improved health, convenience, and the influence of social media. This trend presents both challenges and opportunities for the food and pharma industry. This can be attributed to consumer education, health awareness and consciousness.
Geographically the free Media market is divided into five key regions, i.e. Europe, North America, Latin America, Asia-Pacific, and The Middle East & Africa. The North America D-Mannose market is particularly the United States is expected to hold a significant share of the global D-Mannose market due to its high disposable income rate and the prevalence of UTIs. Also, the awareness of the supplementation becomes a good driver for the market. Additionally, the increased number of R&D activities in North America compared to other countries also drives the market. The Asia Pacific is expected to notice the most growth during the forecast period owing to a rise in disposable income, emerging manufacturers of pharmaceuticals which include D-mannose, and the high population base in India and China which leads to a huge number of UTIs will drive market growth even further.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 726.9 million |
|
Market CAGR |
3.6% |
|
By Product Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The D-Mannose Markets was valued at US$ 726.9 million in 2023 and is expected to witness a CAGR of 3.8% over the forecast period 2024 - 2030.
Major companies operating within the Global D-Mannose Market are Atrium Innovations, E.I. du Pont de Nemours, and International Flavors & Fragrances Inc.
The primary driver is the demand for D-Mannose in the prevalence of diseases like UTI and carbohydrate-deficient glycoprotein syndrome type 1-b coupled with increased healthcare spending and rising awareness about healthier alternatives which include d-Mannose.
North America, particularly the United States, leads in the Global D-Mannose Market due to the high disposable income rate and the prevalence of the UTI’s.
| 1.Executive Summary |
| 2.Global D-Mannose Market Introduction |
| 2.1.Global D-Mannose Market - Taxonomy |
| 2.2.Global D-Mannose Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global D-Mannose Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global D-Mannose Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global D-Mannose Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Powder |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Capsules |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Tablets |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global D-Mannose Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Dietary Supplements |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pharmaceuticals |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Animal Feed |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global D-Mannose Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America D-Mannose Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Powder |
| 8.1.2.Capsules |
| 8.1.3.Tablets |
| 8.1.4.Others |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Dietary Supplements |
| 8.2.2.Pharmaceuticals |
| 8.2.3.Animal Feed |
| 8.2.4.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe D-Mannose Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Powder |
| 9.1.2.Capsules |
| 9.1.3.Tablets |
| 9.1.4.Others |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Dietary Supplements |
| 9.2.2.Pharmaceuticals |
| 9.2.3.Animal Feed |
| 9.2.4.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) D-Mannose Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Powder |
| 10.1.2.Capsules |
| 10.1.3.Tablets |
| 10.1.4.Others |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Dietary Supplements |
| 10.2.2.Pharmaceuticals |
| 10.2.3.Animal Feed |
| 10.2.4.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) D-Mannose Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Powder |
| 11.1.2.Capsules |
| 11.1.3.Tablets |
| 11.1.4.Others |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Dietary Supplements |
| 11.2.2.Pharmaceuticals |
| 11.2.3.Animal Feed |
| 11.2.4.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America D-Mannose Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Powder |
| 12.1.2.Capsules |
| 12.1.3.Tablets |
| 12.1.4.Others |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Dietary Supplements |
| 12.2.2.Pharmaceuticals |
| 12.2.3.Animal Feed |
| 12.2.4.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.International Flavors & Fragrances Inc. |
| 13.2.2.Inner Mongolia Ever Brilliance Biotechnology Co., Ltd |
| 13.2.3.Hangzhou KAIXIN Technology Limited Company |
| 13.2.4.Biosynth |
| 13.2.5.Shaanxi Yuantai Biological Technology Co., Ltd. |
| 13.2.6.Fengchen Group Co.,Ltd |
| 13.2.7.Pfanstiehl, Inc |
| 13.2.8.E.I. du Pont de Nemours |
| 13.2.9.Hanseler AG |
| 13.2.10.Kyowa Hakko Kirin Co Ltd. |
| 13.2.11.VWR Corporation |
| 13.2.12.Nutraceutical International Corporation |
| 13.2.13.Bio-Tech Pharmacal Inc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Sravani is a proficient Business Analyst with an MBA and a background in Computer Science, with seven years of experience in the field of market research. Sravani is adept at creating competitive evaluations, precise market estimations, and market projections, emphasizing the food and beverage and information and communication technology (ICT) industries. Her areas of competence are identifying important players, projecting market trends, and assessing the potential for industry growth. She applies a strong analytical approach to provide precise market estimates and thorough industry analysis, empowering organizations to make data-driven decisions. Sravani's estimating and forecasting abilities are essential for businesses to take advantage of new opportunities and effectively manage dynamic market environments.